List of works - Jennifer Loftis

4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia

scientific article published in March 2003

A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.

scientific article published on 7 August 2014

A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.

scientific article

A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

scientific article published on 9 February 2007

Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression.

scientific article published on 12 November 2012

Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats.

scientific article published on 31 October 2006

Alcohol intake alters immune responses and promotes CNS viral persistence in mice

scientific article published on 4 June 2016

Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine

scientific article

Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder

scientific article

Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia

scientific article

Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.

scientific article published in July 2004

Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia

scientific article

Can rodents be used to model interferon-α-induced depressive symptoms?

article

Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit.

scientific article published on 20 September 2002

Cognitive enhancement in combination with 'brain repair' may be optimal for the treatment of stimulant addiction.

scientific article published on 7 March 2011

Commentary: Methamphetamine mediates immune dysregulation in a murine model of chronic viral infection.

scientific article

Comments on the paper ?The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study?

article

Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration ⬇️

scientific article published on August 4, 2011

Depression and antiviral response to interferon-based therapy for hepatitis C virus infection

scientific article

Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha

scientific article published on 6 November 2007

Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C.

scientific article published on 6 August 2010

Drinking alcohol has sex-dependent effects on pair bond formation in prairie voles

scientific article published on 07 April 2014

Effect of epigallocatechin gallate supplementation in schizophrenia and bipolar disorder: an 8-week, randomized, double-blind, placebo-controlled study.

scientific article published on February 2013

Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction.

scientific article published on March 2016

IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.

scientific article

Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms.

scientific article published on 27 June 2013

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders

scientific article

Interferon-?? Treatment of Patients with Hepatitis C

scientific article published on 01 January 2005

Methamphetamine Causes Persistent Immune Dysregulation: A Cross-Species, Translational Report ⬇️

scientific article published on October 17, 2010

Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF

scientific article published on 01 April 2002

Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.

scientific article published on 29 December 2013

Neuroimmune basis of methamphetamine toxicity

scientific article

Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

scientific article

Pain and Opioid Use in Chronic Liver Disease: Optimal Treatment Must Address the Mental Health Care Needs of the Patient ⬇️

scientific article published on October 1, 2013

Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.

scientific article published on 18 January 2018

Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction

scientific article

Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory

scientific article published on 10 May 2017

Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study

scientific article

Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial

scientific article

Psychiatric management of the hepatitis C patient.

scientific article published on January 2006

Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal.

scientific article

Safety of the Treatment of Interferon-Alpha-Induced Depression

article

Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity? ⬇️

scientific article published on June 8, 2011

Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter

scientific article

Sertoli cell therapy: A novel possible treatment strategy for treatment-resistant major depressive disorder

scientific article published on 31 March 2011

Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C ⬇️

scientific article published on January 1, 2010

Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians

scientific article

Sleep disturbance in substance use disorders and comorbid chronic viral infections.

scientific article published on June 2016

Social housing and alcohol drinking in male-female pairs of prairie voles (Microtus ochrogaster).

scientific article published on 18 August 2012

Social transfer of alcohol withdrawal-induced hyperalgesia in female prairie voles.

scientific article published on 27 March 2018

Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy ⬇️

scientific article published on April 28, 2013

The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

scientific article

The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.

scientific article

The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.

scientific article

The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia.

scientific article

The phenomenology and treatment of interferon-induced depression.

scientific article published in October 2004

The relationship between interleukin-6 and functional connectivity in methamphetamine users.

scientific article published on 21 April 2018

Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence

scientific article published on 10 October 2019

Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: A 16-week prospective study ⬇️

scientific article published on November 21, 2012

List of works by Jennifer Loftis

4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia

A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.

A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.

A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression.

Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats.

Alcohol intake alters immune responses and promotes CNS viral persistence in mice

Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine

Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder

Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia

Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.

Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia

Can rodents be used to model interferon-α-induced depressive symptoms?

Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit.

Cognitive enhancement in combination with 'brain repair' may be optimal for the treatment of stimulant addiction.

Commentary: Methamphetamine mediates immune dysregulation in a murine model of chronic viral infection.

Comments on the paper ?The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study?

Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration ⬇️

Depression and antiviral response to interferon-based therapy for hepatitis C virus infection

Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha

Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C.

Drinking alcohol has sex-dependent effects on pair bond formation in prairie voles

Effect of epigallocatechin gallate supplementation in schizophrenia and bipolar disorder: an 8-week, randomized, double-blind, placebo-controlled study.

Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction.

IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.

Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms.

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders

Interferon-?? Treatment of Patients with Hepatitis C

Methamphetamine Causes Persistent Immune Dysregulation: A Cross-Species, Translational Report ⬇️

Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF

Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.

Neuroimmune basis of methamphetamine toxicity

Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Pain and Opioid Use in Chronic Liver Disease: Optimal Treatment Must Address the Mental Health Care Needs of the Patient ⬇️

Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.

Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction

Peripheral immune factors are elevated in women with current or recent alcohol dependence and associated with altered mood and memory

Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study

Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial

Psychiatric management of the hepatitis C patient.

Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal.

Safety of the Treatment of Interferon-Alpha-Induced Depression

Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity? ⬇️

Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter

Sertoli cell therapy: A novel possible treatment strategy for treatment-resistant major depressive disorder

Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C ⬇️

Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians

Sleep disturbance in substance use disorders and comorbid chronic viral infections.

Social housing and alcohol drinking in male-female pairs of prairie voles (Microtus ochrogaster).

Social transfer of alcohol withdrawal-induced hyperalgesia in female prairie voles.

Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy ⬇️

The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.

The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.

The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia.

The phenomenology and treatment of interferon-induced depression.

The relationship between interleukin-6 and functional connectivity in methamphetamine users.

Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence

Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: A 16-week prospective study ⬇️